- IGEA Pharma N.V.: IGEA to get SIX further approval to the 2021 annual report disclosure
- IGEA Pharma N.V.: IGEA PHARMA HAS SIGNED A PRELIMINARY AGREEMENT WITH LMH-AN INDUSTRIAL HOLDING COMPANY-FOR A EURO 6.000.000 COMMITTMENT TO FUND THE COMPLETION OF ITS SWISS CBD EXTRACTION FACILITY
- IGEA Pharma N.V.: IGEA to get SIX approval to delay the 2021 annual report disclosure
IGEA Pharma NV (0AAX:LSE) closed at 0.128, 0.00% below its 52-week high of 0.128, set on Jun 24, 2022.
0.079Mar 31 20220.128Jun 24 2022
Markit short selling activity
|Market cap||39.30m CHF|
|EPS (TTM)||-0.0337 |
Data delayed at least 20 minutes, as of Mar 31 2022 15:49 BST.